These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
292 related items for PubMed ID: 6936401
1. Phorbol ester tumor promoters block the transition from the early to the heme-dependent late program of Friend cell differentiation. Mager D, Bernstein A. J Cell Physiol; 1980 Dec; 105(3):519-26. PubMed ID: 6936401 [Abstract] [Full Text] [Related]
2. The role of heme in the regulation of the late program of Friend cell erythroid differentiation. Mager D, Bernstein A. J Cell Physiol; 1979 Sep; 100(3):467-79. PubMed ID: 489671 [Abstract] [Full Text] [Related]
3. Induction of a novel nuclear protein (p54) by phorbol esters in mouse erythroleukemia (Friend) cells. Mitsuse S, Oishi M. Cancer Res; 1985 Aug; 45(8):3836-42. PubMed ID: 3860288 [Abstract] [Full Text] [Related]
4. Tumor promoter-mediated effects on Friend leukemia cells induced by actinomycin D: flow microfluorometry analysis and erythroid differentiation. Gambari R. Basic Appl Histochem; 1982 Aug; 26(3):163-72. PubMed ID: 7138458 [Abstract] [Full Text] [Related]
5. Role of nonhemoglobin heme accumulation in the terminal differentiation of Friend erythroleukemia cells. Lo SC, Aft R, Mueller GC. Cancer Res; 1981 Mar; 41(3):864-70. PubMed ID: 6936076 [Abstract] [Full Text] [Related]
6. Enhancement of viral gene expression in Friend erythroleukemic cells by 12-O tetradecanoylphorbol-13-acetate. Colletta G, Di Fiore PP, Ferrentino M, Pietropaolo C, Turco MC, Vecchio G. Cancer Res; 1980 Sep; 40(9):3369-73. PubMed ID: 6159074 [Abstract] [Full Text] [Related]
7. Cytochemical characteristics of leukopoietic differentiation in murine erythroleukemic (Friend) cells. Fioritoni G, Bertolini L, Torlontano G, Revoltella R. Cancer Res; 1980 Mar; 40(3):866-72. PubMed ID: 6937242 [Abstract] [Full Text] [Related]
8. Effect of phorbol ester tumor promoters on the expression of melanogenesis in B-16 melanoma cells. Mufson RA, Fisher PB, Weinstein IB. Cancer Res; 1979 Oct; 39(10):3915-9. PubMed ID: 476628 [Abstract] [Full Text] [Related]
9. A phorbol ester-binding inhibitory factor from human placenta. Partial purification, characterization and biological effects. Hamel E, Yamasaki H, Tayot JL. IARC Sci Publ; 1984 Oct; (56):157-64. PubMed ID: 6598799 [Abstract] [Full Text] [Related]
10. Tumor promoter-induced adhesion of the DS19 clone of murine erythroleukemia cells. Yamasaki H, Weinstein IB, Fibach E, Rifkind RA, Marks PA. Cancer Res; 1979 Jun; 39(6 Pt 1):1989-94. PubMed ID: 286635 [No Abstract] [Full Text] [Related]
11. Inhibition by bryostatin 1 of the phorbol ester-induced blockage of differentiation in hexamethylene bisacetamide-treated Friend erythroleukemia cells. Dell'Aquila ML, Nguyen HT, Herald CL, Pettit GR, Blumberg PM. Cancer Res; 1987 Nov 15; 47(22):6006-9. PubMed ID: 3478136 [Abstract] [Full Text] [Related]
12. Intercellular communication, cell differentiation and tumour promotion. Yamasaki H, Enomoto T, Martel N. IARC Sci Publ; 1984 Nov 15; (56):217-38. PubMed ID: 6598800 [No Abstract] [Full Text] [Related]
13. Initiator and promoter induced specific changes in epidermal function and biological potential. Yuspa SH, Hennings H, Lichti U. J Supramol Struct Cell Biochem; 1981 Nov 15; 17(3):245-57. PubMed ID: 7328673 [Abstract] [Full Text] [Related]
14. Effects of 1-beta-D-arabinofuranosylcytosine and phorbol ester on differentiation of human K562 erythroleukemia cells. Watanabe T, Mitchell T, Sariban E, Sabbath K, Griffin J, Kufe D. Mol Pharmacol; 1985 Jun 15; 27(6):683-8. PubMed ID: 3858662 [Abstract] [Full Text] [Related]
15. Membrane interaction and modulation of gene expression by tumor promoters. Yamasaki H, Enomoto T, Hamel E, Kanno Y. Princess Takamatsu Symp; 1983 Jun 15; 14():221-33. PubMed ID: 6240488 [Abstract] [Full Text] [Related]
16. Inhibition of terminal differentiation of hamster epidermal cells in culture by the phorbol ester 12-O-tetradecanoylphorbol-13-acetate. Sisskin EE, Barrett JC. Cancer Res; 1981 Feb 15; 41(2):593-603. PubMed ID: 7448806 [Abstract] [Full Text] [Related]
17. Inhibition of induced differentiation of C3H/10T 1/2 clone 8 mouse embryo cells by tumor promoters. Mondal S, Heidelberger C. Cancer Res; 1980 Feb 15; 40(2):334-8. PubMed ID: 6153153 [Abstract] [Full Text] [Related]
18. The program of Friend cell erythroid differentiation: early changes in Na+/K+ ATPase function. Mager D, Bernstein A. J Supramol Struct; 1978 Feb 15; 8(4):431-8. PubMed ID: 214640 [Abstract] [Full Text] [Related]
19. Heterogeneity of murine erythroleukemia cells with respect to tumor promoter-mediated inhibition of cell differentiation. Fibach E, Yamasaki H, Weinstein IB, Marks PA, Rifkind RA. Cancer Res; 1978 Nov 15; 38(11 Pt 1):3685-8. PubMed ID: 279396 [Abstract] [Full Text] [Related]
20. Protein kinase calpha is an effector of hexamethylene bisacetamide-induced differentiation of Friend erythroleukemia cells. Mallia CM, Aguirre V, McGary E, Tang Y, Scandurro AB, Liu C, Noguchi CT, Beckman BS. Exp Cell Res; 1999 Feb 01; 246(2):348-54. PubMed ID: 9925750 [Abstract] [Full Text] [Related] Page: [Next] [New Search]